In the following, we are pleased to provide an overview of projects with EURAMED involvement.
CONCERT, the European Joint Programme for the Integration of Radiation Protection Research, under Horizon 2020 aimed to contribute to the sustainable integration of European and national research programmes in radiation protection. CONCERT as a co-fund action strove to achieve the attraction and pooling of national research efforts in radiation protection with EURATOM research programmes in order to make better use of public R&D resources and tackle common European challenges in radiation protection more effectively by joint research efforts in key areas. In order to rise to this challenge CONCERT operated as an umbrella structure for the research initiatives of the radiation protection research platforms MELODI, ALLIANCE, NERIS, EURADOS and EURAMED.
EURAMED became a beneficiary of the project after its establishment as a legal entity in early 2018, was represented on the management board, and contributed to the medical aspects of the project. The EC reviewed the project’s progress and achievements on 27 March 2019, finding exceptional results. The project ended in 2020 with the delivery of a joint roadmap for radiation protection research.
For more info, please visit http://www.concert-h2020.eu/
The MEDIRAD project studies the implications of medical low-dose radiation exposure. It aims to enhance the scientific base and clinical practice of radiation protection in the medical field and thereby addresses the need to better understand and evaluate the health effects of low-dose ionising radiation exposure from diagnostic and therapeutic imaging and off-target effects in radiotherapy. The project received €10 million in funding from the European Commission under the Horizon 2020 programme and started in June 2017. MEDIRAD brings together over 70 scientists from 34 organisations in 14 countries and will significantly improve our scientific understanding and practice of radiation protection in the medical field. MEDIRAD is coordinated by EIBIR, with Prof. Elisabeth Cardis (ES) as Scientific Coordinator and Prof. Guy Frija (FR) as Clinical Coordinator.
In the preparation phase EURAMED and its individual medical associations provided strategic guidance and input to the development of the project.
EURAMED is a member of the project stakeholder board, attends the annual consortia meetings to comment on the research work and project progress from a stakeholder perspective and will also be involved in the development of science-based policy recommendations.
For more info, please visit http://www.medirad-project.eu/
The 3-year EURAMED rocc-n-roll project proposes an integrated and coordinated European approach to research and innovation in medical applications of ionising radiation and related radiation protection based on stakeholder consensus and existing activities in the field (incl. existing SRAs of radiation protection platforms, EC health and digitisation programmes, EURATOM-funded projects, and the SAMIRA initiative). To achieve this, research and radiation protection needs in the clinical disciplines using ionising radiation will be analysed with the aim to generate the largest benefit for the European population in an equal, safe and high-quality way throughout Europe by fostering clinical translation while also strengthening economic growth and industrial competitiveness.
The project kicked off in September 2020. It involves 29 project partners from 17 countries and is coordinated by EIBIR with Prof. Christoph Hoeschen (DE) acting as Scientific Coordinator and Prof. Guy Frija (FR) as Clinical Coordinator.
EURAMED chairs the project advisory board and is involved in various project panels. Moreover, EURAMED members are directly involved as project beneficiaries.
For more info, please visit https://roccnroll.euramed.eu/
The 4-year SINFONIA project will develop novel methodologies and tools that will provide a comprehensive risk appraisal for detrimental effects of radiation exposure on patients, workers, carers and comforters, the public and the environment during the management of patients suspected or diagnosed with lymphoma and brain tumours.
The project started in September 2020. The multidisciplinary project consortium combines the expertise of 14 partners from 8 countries. It includes major universities, research institutes, hospitals and industry partners.
SINFONIA is coordinated by EIBIR with Prof. John Damilakis (GR) acting as Scientific Coordinator. Many EURAMED representatives are directly involved in the project as beneficiaries and are responsible for the implementation of key deliverables.
For more info, please visit https://www.sinfonia-appraisal.eu
In answer to the Euratom call NRT-01-09, the project PIANOFORTE will begin in 2022 to consolidate an EU-wide research and innovation community in the field of radiation protection to support the EU and national authorities, thus ensuring progress with new knowledge, innovative methods, technologies and skills to address current knowledge gaps, societal concerns and emerging issues. An integrated approach will exploit synergies between various areas of expertise, including cancer diagnosis and treatments; medical, industrial or environmental exposure; and emergency management in relation to accidents involving radiation, to maximise benefits and outcomes. The consortium, largely based on the integration effort accomplished by the radiation protection research community over the previous decade and supported within Horizon 2020 and EC/EURATOM research programme frameworks, will be under the leadership of the French Institute for Radiological Protection and Nuclear Safety (IRSN) and include many national radiation research and protection agencies and each of the MEENAS platforms. Always considering radiation safety, the vision supported by this partnership is to provide both a pan-European scientific and technological basis for a robust system of protection and more consolidated science-based policy recommendations to decision makers in many different fields and innovation in ionising-radiation-based medical applications combating cancer and other diseases by new and optimised diagnostic and therapeutic approaches. In the long term, these efforts will translate into additional or improved practical measures and improved scientific insights in view of better outcomes for patients suffering from cancer and the effective protection of the public, workers, patients and environment.
PIANOFORTE will build on the results of past (DoReMi, OPERRA, COMET, CONCERT) and current (EURAMED Rocc-n-Roll, MEDIRAD, HARMONIC, RadoNorm, SINFONIA) projects, particularly the recently published joint roadmap for radiation protection research of CONCERT. Seven work packages will fulfill the project tasks and objectives.
PIANOFORTE was introduced during the MEENAS webinar on May 6.